CT-721 is a potent, time-dependent Bcr-Abl kinase inhibitor with an IC50 of 21.3 nM against wild-type Bcr-Abl kinase, exhibiting anti-chronic myeloid leukemia (CML) activity.
Molecular Weight:
525.04
CAS Number:
[1388710-60-8]
Formula:
C30H29ClN6O
Target:
Others|||Bcr-Abl
T10897
* VAT and and shipping costs not included. Errors and price changes excepted